Survivor  fund Youth Investment Fund Portal INEC Recruitment 2020 of Ad-hoc Staff
Connect with us

World News

COVID-19: WHO discontinues hydroxychloroquine treatment

Published

on

The World Health Organization (WHO) has on Saturday July 4,2020, discontinued hydroxychloroquine and Lopinavir/ritonavir treatment, the Organization’s action was customary to recommendations to cease the treatment by Solidarity Trial’s International Steering Committee.

Solidarity Trial’s International Steering Committee is an arm of WHO established to find an effective treatment for COVID-19 patients.

The formulation to discontinue the trail was reached by the International Steering Committee after a proper review of trial results presented at WHO Summit on COVID-19 research and innovation, held between July 1st and 2nd, 2020.

Provisional trial results at the Summit indicates that hydroxychloroquine and lopinavir/ritonavir contribute little or no significant effect on the mortality of Coronavirus patients when compared standard of care.

Although, the results for each of the drugs, does not present concrete evidence of increased mortality, there are some mix of assurance signs in the clinical laboratory discoveries of the extra trial findings.

Nevertheless, WHO’s decision only applies to the administration of unified treatments to COVID-19 patients and does not affect the evaluation of the drugs in other studies or as a pre-exposure or post-exposure prophylaxis for the virus.

RSS
Latest Jobs in Nigeria

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending News